Brenda Diane Jamerson | Scholars@Duke

Brenda Diane Jamerson
Adjunct Assistant Professor in Psychiatry and Behavioral Sciences

Current Appointments & Affiliations

Adjunct Assistant Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2003
Core Member of the Center for Biobehavioral Health Disparities Research, Center on Biobehaviorial Health Disparities Research, Social Science Research Institute 2014

Contact Information

brenda.d.jamerson@duke.edu

Background
Education, Training, & Certifications
- Pharm.D., Ohio State University 1986
Recognition
In the News
- JUN 23, 2016 News-Medical
  
  Study helps identify traits that may cause elders to need help with medications
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Jamerson, Brenda D., T Ho Haryadi, and Arline Bohannon. “Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?” Arch Med Res, June 7, 2020. https://doi.org/10.1016/j.arcmed.2020.06.006.
    Full Text Link to Item
  - Jamerson, Brenda D., and T Ho Haryadi. “The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?” Medical Hypotheses 144 (May 25, 2020): 109880. https://doi.org/10.1016/j.mehy.2020.109880.
    Full Text
  - Jamerson, Brenda D., Gerda G. Fillenbaum, Richard Sloane, and Miriam C. Morey. “A New Method of Identifying Characteristics of Needing Help to Take Medications in an Older Representative Community-Dwelling Population: The Older Adults Medication Assist Scale.” J Am Geriatr Soc 64, no. 6 (June 2016): 1195–1202. https://doi.org/10.1111/jgs.14166.
    Full Text Link to Item
  - Jamerson, Brenda D., Martha E. Payne, Melanie E. Garrett, Allison E. Ashley-Koch, Marcy C. Speer, and David C. Steffens. “Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression.” Int J Geriatr Psychiatry 28, no. 9 (September 2013): 925–32. https://doi.org/10.1002/gps.3899.
    Full Text Link to Item
  - Herring, Charles, Andrew J. Muzyk, Brenda Jamerson, Carolyn F. Pedley, Ellyn Smith, David Price, and Yoronda Jones. “Use of antidepressants for the treatment of psychiatric illnesses.” Journal of Pharmacy Practice 23, no. 4 (August 2010): 374–75. https://doi.org/10.1177/0897190010366926.
    Full Text
  - Herring, Charles, Andrew J. Muzyk, and Brenda Jamerson. “Treatment of comorbid depression in medical illness.” Journal of Pharmacy Practice 23, no. 3 (June 2010): 274–76. https://doi.org/10.1177/0897190010366924.
    Full Text
  - Payne, Martha E., Brenda D. Jamerson, Christopher F. Potocky, Allison E. Ashley-Koch, Marcy C. Speer, and David C. Steffens. “Natural food folate and late-life depression.” J Nutr Elder 28, no. 4 (October 2009): 348–58. https://doi.org/10.1080/01639360903417181.
    Full Text Link to Item
  - Hatsukami, Dorothy K., Stephen Rennard, Manoj K. Patel, Michael Kotlyar, Robert Malcolm, Mitchell A. Nides, Greg Dozier, Matthew P. Bars, and Brenda D. Jamerson. “Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking.” The American Journal of Medicine 116, no. 3 (February 2004): 151–57. https://doi.org/10.1016/j.amjmed.2003.07.018.
    Full Text
  - Jamerson, Brenda D., K Ranga Rama Krishnan, Jeremy Roberts, Alok Krishen, and Jack G. Modell. “Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.” Psychopharmacology Bulletin 37, no. 2 (January 2003): 67–78.
  - Jain, Adesh K., Roy A. Kaplan, Kishore M. Gadde, Thomas A. Wadden, David B. Allison, Edwin R. Brewer, Robert A. Leadbetter, et al. “Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.” Obes Res 10, no. 10 (October 2002): 1049–56. https://doi.org/10.1038/oby.2002.142.
    Full Text Link to Item
  - Fleisher, L. A., S. Hogue, M. Colopy, R. S. Twersky, D. S. Warner, B. D. Jamerson, K. J. Tuman, P. S. Glass, and M. F. Roizen. “Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia?” J Clin Anesth 13, no. 6 (September 2001): 401–6. https://doi.org/10.1016/s0952-8180(01)00291-4.
    Full Text Link to Item
  - Twersky, R. S., B. Jamerson, D. S. Warner, L. A. Fleisher, and S. Hogue. “Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients.” J Clin Anesth 13, no. 6 (September 2001): 407–16. https://doi.org/10.1016/s0952-8180(01)00292-6.
    Full Text Link to Item
  - Joshi, G. P., B. D. Jamerson, M. F. Roizen, L. Fleisher, R. S. Twersky, D. S. Warner, and M. Colopy. “Is there a learning curve associated with the use of remifentanil?” Anesth Analg 91, no. 5 (November 2000): 1049–55. https://doi.org/10.1097/00000539-200011000-00002.
    Full Text Link to Item
  - Balakrishnan, G., P. Raudzens, S. K. Samra, K. Song, J. A. Boening, V. Bosek, B. D. Jamerson, and D. S. Warner. “A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions.” Anesth Analg 91, no. 1 (July 2000): 163–69. https://doi.org/10.1097/00000539-200007000-00030.
    Full Text Link to Item
  - Hogue, S. L., P. R. Reese, M. Colopy, L. A. Fleisher, K. J. Tuman, R. S. Twersky, D. S. Warner, and B. Jamerson. “Assessing a tool to measure patient functional ability after outpatient surgery.” Anesth Analg 91, no. 1 (July 2000): 97–106. https://doi.org/10.1097/00000539-200007000-00019.
    Full Text Link to Item
  - Warner, D. S., B. D. Jamerson, G. Balakrishnan, J. Boening, V. Bosek, P. Raudzens, S. Samra, and K. Song. “Real-world comparison of fentanyl versus remifentanil based anesthesia for craniotomy.” Anesthesiology 89, no. 3A (September 1, 1998): U324–U324.
    Link to Item
  - Class, P. S. A., B. D. Jamerson, M. Colopy, L. A. Fleisher, M. F. Roizen, K. Tuman, R. Twersky, and D. S. Warner. “Is there a difference in adverse events during general anesthesia based on gender, age, or ethnic group.” Anesthesia and Analgesia 86, no. 2S (February 1, 1998): U115–U115.
    Link to Item
  - Warner, D. S., B. D. Jamerson, M. Colopy, L. A. Fleisher, P. S. A. Glass, M. F. Roizen, K. Tuman, and R. Twersky. “Adverse events during general anesthesia with remifentanil: A phase IV comparison trial.” Anesthesia and Analgesia 86, no. 2S (February 1, 1998): U126–U126.
    Link to Item
  - Warner, D. S., B. J. Hindman, M. M. Todd, P. D. Sawin, J. Kirchner, C. L. Roland, and B. D. Jamerson. “Intracranial pressure and hemodynamic effects of remifentanil versus alfentanil in patients undergoing supratentorial craniotomy.” Anesth Analg 83, no. 2 (August 1996): 348–53. https://doi.org/10.1097/00000539-199608000-00025.
    Full Text Link to Item
- Conference Papers
  - Stillwell, T., C. Robbins, A. Riley, M. Ahmed, and B. D. Jamerson. “Planning and implementation of a multimodal medication error tracking, reporting and prevention program.” In Pharmacotherapy, 24:1477–1477. PHARMACOTHERAPY PUBLICATIONS INC, 2004.
    Link to Item
  - Jain, A. K., R. A. Kaplan, K. M. Gadde, T. A. Wadden, D. B. Allison, E. R. Brewer, R. A. Leadbetter, R. M. J. Donahue, K. S. Buaron, and B. D. Jamerson. “A study of bupropion SR compared to placebo in obese adults with mild to moderate depressive symptoms.” In Obesity Research, 9:68S-68S. NORTH AMER ASSOC STUDY OBESITY, 2001.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

In the News

Selected Publications

Academic Articles

Conference Papers